Intech Investment Management LLC Trims Stake in Kenvue Inc. $KVUE

Key Points

• Intech Investment Management LLC reduced its stake in Kenvue Inc. by 37%, now holding 142,047 shares valued at approximately $3.4 million.
• Kenvue has recently declared an increase in its quarterly dividend to $0.2075 per share, reflecting a dividend yield of 4.4% and a payout ratio of 112.16%.
• The company reported $3.84 billion in revenue for the last quarter, which was lower than analysts' expectations, and set its FY 2025 earnings per share guidance at 1.000-1.050.

Intech Investment Management LLC reduced its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 37.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 142,047 shares of the company's stock after selling 83,261 shares during the quarter. Intech Investment Management LLC's holdings in Kenvue were worth $3,406,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of KVUE. Starboard Value LP bought a new stake in Kenvue during the fourth quarter worth $467,864,000. Vanguard Group Inc. lifted its holdings in Kenvue by 4.9% during the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company's stock worth $5,494,882,000 after acquiring an additional 10,600,682 shares during the period. Third Point LLC bought a new stake in Kenvue during the first quarter worth $213,422,000. Maverick Capital Ltd. bought a new stake in Kenvue during the first quarter worth $203,036,000. Finally, Nuveen LLC bought a new stake in Kenvue during the first quarter worth $187,123,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on KVUE shares. Bank of America decreased their target price on Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Tuesday, July 15th. UBS Group decreased their target price on Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Royal Bank Of Canada decreased their target price on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research report on Friday, August 8th. Canaccord Genuity Group decreased their target price on Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Finally, Barclays decreased their target price on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, July 15th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Kenvue currently has a consensus rating of "Hold" and an average target price of $24.04.

Kenvue Trading Up 1.0%

Shares of NYSE KVUE traded up $0.18 during midday trading on Wednesday, reaching $18.31. The company had a trading volume of 11,417,508 shares, compared to its average volume of 18,402,367. Kenvue Inc. has a one year low of $17.15 and a one year high of $25.17. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The firm's fifty day moving average price is $21.04 and its 200-day moving average price is $22.16. The stock has a market cap of $35.13 billion, a PE ratio of 24.74, a price-to-earnings-growth ratio of 2.62 and a beta of 0.83.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue's quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is currently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.